Our studies have also demonstrated that adenovirus-mediated interference with FOXM1 expression impedes the progression of liver cancer [54], breast cancer [13], and nasopharyngeal carcinoma [55]. Here, FOXM1 is linked to nasopharyngeal carcinoma.